|
TMEM41A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.974340E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53790000000576E-05 |
| Normal-vs-Stage2 |
1.810970E-04 |
| Normal-vs-Stage3 |
3.565900E-02 |
| Normal-vs-Stage4 |
3.894000E-01 |
| Stage1-vs-Stage2 |
4.891800E-01 |
| Stage1-vs-Stage3 |
6.795600E-02 |
| Stage1-vs-Stage4 |
1.536220E-03 |
| Stage2-vs-Stage3 |
7.574500E-02 |
| Stage2-vs-Stage4 |
6.415600E-03 |
| Stage3-vs-Stage4 |
2.789400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.991900E-04 |
| Normal-vs-AfricanAmerican |
9.093700E-02 |
| Normal-vs-Asian |
5.272000E-01 |
| Caucasian-vs-AfricanAmerican |
5.651400E-01 |
| Caucasian-vs-Asian |
5.028800E-01 |
| AfricanAmerican-vs-Asian |
6.122800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.352100E-04 |
| Normal-vs-Female |
6.861500E-03 |
| Male-vs-Female |
1.954620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.054600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.539380E-03 |
| Normal-vs-Age(61-80Yrs) |
1.821320E-04 |
| Normal-vs-Age(81-100Yrs) |
1.215430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.666400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.759800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.498200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.482600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.305600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.675200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.884900E-03 |
| Normal-vs-Grade 2 |
1.010460E-04 |
| Normal-vs-Grade 3 |
9.356800E-04 |
| Normal-vs-Grade 4 |
7.134800E-01 |
| Grade 1-vs-Grade 2 |
8.139600E-01 |
| Grade 1-vs-Grade 3 |
6.286600E-01 |
| Grade 1-vs-Grade 4 |
2.602200E-02 |
| Grade 2-vs-Grade 3 |
6.758800E-01 |
| Grade 2-vs-Grade 4 |
9.817800E-03 |
| Grade 3-vs-Grade 4 |
2.141900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.01189994956053E-09 |
| Normal-vs-ccB subtype |
1.147770E-01 |
| ccA subtype-vs-ccB subtype |
6.983400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.638700E-03 |
| Normal-vs-N1 |
1.521640E-01 |
| N0-vs-N1 |
1.259480E-03 |
|
|
